《大行報告》瑞信微降港交所(00388.HK)目標價至432元 評級「跑贏大市」
瑞信發表報告,預期港交所(00388.HK)今年第二季收入達45億元,按季下跌4%,按年計則倒退9%。而次季的日均成交額按季及按年料均錄得較大下跌,估計分別減少11%及14%。
盈利方面,該行預期港交所第二季純利爲25億元,按季下跌7%,按年則倒退10%。展望未來,瑞信料集團將有數個潛在催化劑,包括互聯互通計劃擴展、中概股加快在港上市/轉換成H股、新股市場回暖,及HIBOR上升和股票市場穩定。
瑞信微降港交所股份目標價,由434元下調至432元,評級維持「跑贏大市」,並輕微調低集團今年每股盈測1.9%,反映淨投資收益預測下調。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.